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Combined use of bioassay-guided fractionation based on in vitro antiplasmodial assay and dereplication
based on HPLC–PDA–MS–SPE–NMR led to isolation of (6S,7R,8S)-14-acetoxy-8-[2-hydroxymethylacry-
lat]-15-helianga-1(10),4,11(13)-trien-15-al-6,12-olid and (5R,6R,7R,8S,10S)-14-acetoxy-8-[2-hydroxy-
methylacrylat]-elema-1,3,11(13)-trien-15-al-6,12-olid, along with vernodalol, vernodalin, and 11,13b-
dihydroxyvernodalin from extract of Distephanus angulifolius. All compounds were identiﬁed by spectro-
scopic methods, including 1D and 2D homo- and heteronuclear NMR experiments. The isolated com-
pounds showed IC50 values in the range 1.6–3.8 lM and 2.1–4.9 lM against chloroquine sensitive D10
and chloroquine resistant W2 Plasmodium falciparum strains, respectively.
 2009 Elsevier Ltd. All rights reserved.1. Introduction
Drug discovery based on results from in vitro antiplasmodial
bioassays, i.e., bioassay-guided isolation, has revealed many active
constituents from complex mixtures of biological origin, e.g., plant
extracts, marine organisms, and microorganisms. However, the
method suffers from several problems, including limited compat-
ibility with high-throughput technologies typically used in phar-
maceutical drug discovery programmes (Butler, 2004), results
from in vitro assays do not necessarily reﬂect in vivo activity (Bour-
dy et al., 2008), need for time-consuming preparative-scale isola-
tion for in vitro bioassays, and the risk of spending time on
isolation of known compounds with known activity. Urgent need
for new antimalarial drug candidates calls for alleviation of some
of these drawbacks, and the latter can be partly solved by applying
chemical screening technologies that identiﬁes the extract-con-
stituents before or simultaneous with the bioassay-guided frac-
tionation. Although LC–MS is a fast and sensitive technique that
is frequently used for chemical screening, mass spectrometry lacks
the possibility of rigorous structure elucidation that is provided by
NMR spectroscopy. In a series of recent papers, it has been demon-
strated that hyphenated HPLC–SPE–NMR is a fast, sensitive andll rights reserved.
45 35332398.efﬁcient technique for analytical-scale identiﬁcation of constitu-
ents in complex mixtures (Clarkson et al., 2006a; Schmidt et al.,
2008; Sprogøe et al., 2007; Sørensen et al., 2007; Tatsis et al.,
2007), including full structure elucidation of even very complex
structures (Clarkson et al., 2006b) and assignment of absolute ste-
reochemistry by combining the technique with circular dichroism
(Sprogøe et al., 2008). The HPLC–SPE–NMR technique has been ex-
tended to include direct on-line identiﬁcation of radical scaveng-
ing activity (Pukalskas et al., 2005), but the simultaneous
identiﬁcation of chemical structure and biological activity is not
possible in most cases. In this work, the two complementary strat-
egies, i.e., chemical screening based on HPLC–PDA–MS–SPE–NMR
and biological screening based on results from in vitro antiplasmo-
dial assays, were performed simultaneous on an extract of Disteph-
anus angulifolius (DC.) H. Rob. & B. Kahn [syn. Vernonia angulifolia
DC.] (Robinson and Kahn, 1986) to avoid preparative-scale isola-
tion of uninteresting constituents, both in terms of chemical struc-
ture and biological activity.
Distephanus and Vernonia are closely related genera within the
Asteraceae (Robinson, 2006), but whereas phytochemical informa-
tion on Distephanus is scarce (Jakupovic et al., 1987), Vernonia is
known to be a rich source of sesquiterpene lactones. Vernonia amy-
gdalina is probably one of the most intensively investigated Verno-
nia species due to reports of its use as an antiparasitic remedy by
wild chimpanzees (Huffman and Seifu, 1989; Jisaka et al., 1992;
Fig. 1. HPLC-PDA-MS-SPE-NMR analysis of defatted extract of V. angulifolia aerial
parts using UV-trace at 220 nm (grey) or 254 nm (black) for threshold-based
adsorption on SPE cartridges. Constituents were identiﬁed as chlorogenic acid
analogs (peak 1–3), vernodalol (peak 4), vernodalin (peak 5), 11,13-dihydrover-
nodalin (peak 6), 1 (peak 7), 2 (peak 9) and several unidentiﬁed steroid saponins
(peak 8, 10–17) [Phenomenex Luna C18(2) column, 150  4.6 mm i.d., 3 lm, ﬂow
rate 0.8 ml/min, acetonitrile gradient in water (0.1% formic acid) as shown].
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including antitumoral (Jisaka et al., 1993), antibacterial (Erasto
et al., 2006; Rabe et al., 2002; Reid et al., 2001), antioxidant (Erasto
et al., 2007), anti-inﬂammatory (Ciofﬁ et al., 2004), insect antifee-
dant (Ganjian et al., 1983), and cytotoxicity (Koul et al., 2003), have
been reported from various Vernonia species.
Distephanus angulifolius is a scrambling shrub or climber which
in South Africa is found from the Eastern Cape to Mozambique. It is
commonly known as ‘‘Trailing Vernonia” due to its growth habit,
and in Zulu, it is called impoqompoqwane. According to Pooley
(1998), D. angulifolius is used traditionally to treat stomach ail-
ments, and an earlier investigation reported the presence of four
germacranolide-type sesquiterpene lactones (Bohlmann et al.,
1978). In this work, aerial parts were investigated for constituents
responsible for the antiplasmodial constituents.
2. Results and discussion
HPLC–PDA–MS–SPE–NMR was used for initial analysis of a
defatted dichloromethane-methanol extract (extract A) of D. angu-
lifolius. A total of 17 peaks were analyzed (Fig. 1), showing the pres-
ence of chlorogenic acid analogs (peak 1–3), vernodalol (peak 4, 3),
vernodalin (peak 5, 4), 11,13-dihydrovernodalin (peak 6, 5), com-
pound 1 (peak 7), compound 2 (peak 9), and several steroid sapo-
nins (peak 8 and 10–17). Structural formulae of all isolated
sesquiterpene lactones are shown in Fig. 2. In a concurrent study,
bioassay-guided isolation of an acetone extract revealed two frac-
tions giving less than 10% survival of chloroquine sensitive P. falci-
parum parasites in vitro, and 1H NMR spectral data indicated the
presence of sesquiterpene lactones. Based on these results, pre-
parative-scale HPLC of the defatted extract was performed aiming
at isolation of the sesquiterpene lactones. This afforded 3 and a
fraction, which after being rechromatographed using analytical-
scale HPLC with automated fraction collection, yielded 4, 5, and a
mixture of 6 and 7 (2:1). Due to the limited amount, 6 and 7 were
not further puriﬁed but their identity established within the
mixture.
Further bioassay-guided fractionation of the two fractions of the
acetone extract by column chromatography and preparative-scale
TLC yielded 1, 2, 3, and a mixture of 4 and 5 as the active principles.
Compound 1 was assigned the molecular formula C21H24O8 as
determined by HRMS (m/z 427.1369 [M+Na]+). The structure was
established by correlations found in 2D COSY, NOESY, HSQC andHMBC spectra, and full assignment of all correlations are given in
Supplementary Table 1. Thus, the H-1?H-2?H-3 and the
H-5?H-6?H-7?H-8?H-9 spin systems were identiﬁed by the
COSY experiments and these fragments were, together with C-4
andC-10, combined by correlations observed in theHMBC spectrum
(Fig. 3), to form the 10-membered cyclic carbon skeleton. Similarly,
HMBC were used for showing the position of the aldehyde, the 2-
(hydroxymethyl)acrylate, and the acetyl groups at C-4, C-8, and
C-14, respectively. The relative conﬁguration of 1 was established
by analysis of 1H coupling patterns and the NOESY spectrum. Thus,
using H-7 as anchoring point, strong NOESY cross peaks to H-1, H-5
and H-9a showed their position below the plane of the ring (Fig. 3).
Similarly, NOESY correlations between H-1, H-5 and H-15 con-
ﬁrmed their a-position and thus the E-conﬁguration of the
C4C5 double bond. The E-conﬁguration was further conﬁrmed
by the down-ﬁeld position (d 6.54) of H-5 and the up-ﬁeld position
(d 9.52) of H-15 (Fortuna et al., 2001) as compared to related com-
pounds with Z-conﬁguration (dH-5  6.11, dH-15  10.2, respec-
tively) (Seaman and Fischer, 1980). The 1,2-trans-diaxial relation
between H-7 and H-8 was evident from their large coupling con-
stant (3JH7H8 = 9.8 Hz) which leads to the b-pseudoaxial position
of H-8 and consequently the a-pseudoequatorial position of the
2-(hydroxymethyl)acrylate group. Based on the b-position of H-8,
the NOESY correlation network illustrated on the right-hand side
of Fig. 3 conﬁrms the position of H-3b, H-6, H-9b and the acetyl
group above the plane, and thus the Z-conﬁguration of the
C1–C10 double bond. These observations and comparison of the
negative optical rotation (½a20D = 9.2) of 1with the optical rotation
of a related structure with 6R,7R,8S conﬁguration (Roselli et al.,
2003), leads to the 1(10)-Z,4-E,6R,7R,8S conﬁguration of 1.
Compound 1 is a new compound for which the name vernangulide
A is proposed. A related structure with an acetyl instead of a
2-(hydroxymethyl)acrylate at C-8 has previously been isolated
from Mikinia minima (Asteraceae) (Cuenca et al., 1993).
Compound 2 was assigned the molecular formula C21H24O8
based on HRMS (m/z 427.1442 [M+Na]+), and analysis of 2D COSY,
NOESY, HSQC and HMBC experiments (see Supplementary Table 2)
established the structure of this elemanolide analogue. Thus, the
axial position of H-5, H-6, H-7 and H-8 of the pseudo-chair-formed
cyclohexane was evident from the coupling constants
(3JH5;H6 = 12.3, 3JH6;H7 = 11.3, 3JH7;H8 = 11.0). This led conse-
quently to the equatorial position of the 3-oxopropen-2-yl and 2-
(hydroxymethyl)acrylate groups, which were identiﬁed as substit-
uents at C-5 and C-8, respectively, by HMBC correlations. The chair
form of the cyclohexane moiety was further supported by strong
NOESY cross peaks between H-6 and H-8, and between H-5, H-7
and H-9ax, due to their 1,3-diaxial position. The vinyl group at C-
10 was positioned equatorial (a-position) based on NOESY correla-
tions from H-1 and H-2 to H-5, H-7 and H-9ax, thus leading to axial
position (b-position) of the acetoxymethyl group. This axial posi-
tion is in agreement with NOESY correlations observed between
H-14A and H-9 eq, and between H-14B and H-6, H-8, and H-3B.
The different NOE correlations observed for H-14A and H-14B is
in agreement with the preferred conformation of 2 obtained by
molecular modeling. Thus, the preferred orientation of the 3-oxo-
propen-2-yl, the vinyl and the acetoxymethyl groups were as-
sessed by continuously calculating minimized molecular energy
levels when employing a dihedral driver schedule with a resolution
of 1 for the C3–C4–C5–C10, C2–C1–C10–C5 and C9–C10–C14–O14
dihedral angles, respectively. The obtained model (Fig. 4) shows
that the cyclohexane moiety of 2 adopts a pseudo-chair conforma-
tion with orientation of the side chains that correlates with the ob-
served NOESY correlations. Previous work (Karamenderes et al.,
2007) with a related structure (8) concludes, based on the observa-
tion of a small, rather than a strong, ROESY cross peak between
H-14a and H-6, that 8 adopts a boat conformation. This conclusion is
Fig. 2. Structure of compounds 1–8.
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ular modeling study, which both suggest a chair conformation. In
addition, there is no further evidence for the boat-conformation,
e.g., information about a strong ROE between H-6 and H-9b, or
other ROE’s supporting the boat conformation. In this study, both
coupling constants, observed NOE’s and molecular modeling stud-
ies suggests that the cyclohexane part of 2 adopts a pseudo-chair
conformation. The absolute conﬁguration of 2 is 5R,6R,7R,8S,10R
based on comparison of the optical rotation (½a20D = +26.3) with
data from related structures possessing the same chiral skeleton
with achiral substituents (Roselli et al., 2003; Karamenderes
et al., 2007; Cardona et al., 1997). Compound 2 is a new compound
for which the name vernangulide B is suggested.
Compounds 3–5 were identiﬁed as vernodalol, vernodalin and
11,13b-dihydrovernodalin, respectively, based on comparison ofspectroscopic data (optical rotation, 1H and 13C NMR; see Supple-
mentary Tables 3–5) with data from literature (Erasto et al.,
2007; Abegaz et al., 1994; Reid et al., 2001; Al Magboul et al.,
1997) as well as by full assignment of 1D and 2D NMR spectro-
scopic data.
Compounds 6 and 7were isolated as a mixture and identiﬁed as
the C6,C12-ring-opened forms of vernodalin and 11,13b-dihydr-
overnodalin. Lactones exist in equilibrium with their ring-opened
analogs, and consequently 6 and 7 should not be considered as
independent compounds. However, because 6 and 7 could be iso-
lated as the ring-opened form without their lactonized analogs,
1H NMR data are given for future reference (Supplementary Tables
6 and 7).
Antiplasmodial activity of 1–4 against chloroquine sensitive
D10 and chloroquine resistant W2 P. falciparum strains are shown
Fig. 3. Selected correlations from 2D COSY, HMBC and NOESY experiments. Left: Spin systems found by COSY shown with bold lines; HMBC correlations (H ? C) used for
establishment of skeleton. Middle: NOE correlations for hydrogens positioned below plane of ring system. Right: NOE correlations for hydrogens positioned above plane of
ring system [1H resonance frequency 400 MHz; acetone-d6; double-quantum ﬁltered COSY; phase-sensitive NOESY, mixingtime of 600 ms; gradient-selected HMBC,
nJC;H = 7.7 Hz].
Fig. 4. Model of preferred conformation of 2 [ChemBio3D Ultra, dihedral driver
(resolution 1) with calculated energy minima (MM2) for each step].
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range against both D10 and W2 strains. Compounds 1 and 2 show
slightly better effect than 3, with 2 having the lowest resistance in-
dex. Compounds 2 and 3 show a selectivity index 2.8 and 3.6 times
higher, respectively, than 1.
3. Conclusion
In this work, fast dereplication of extract constituents avoided
time-consuming preparative-scale isolation of steroid saponins,
which due to their amphiphilic and/or detergent properties are
likely to give false-positive response in in vitro antiplasmodial as-
says due to membrane alterations (Ziegler et al., 2002, 2004;
Sairaﬁanpour et al., 2003). In addition, results from bioassay-
guided fractionation targeted preparative-scale isolation towards
the sesquiterpene lactones. It is well-established that sesquiter-
pene lactones possess a general cytotoxicity mediated by their
a,b-unsaturated carbonyls (Scotti et al., 2007; Zhang et al., 2005).
These structural elements react with cystein sulfhydryl groups by
a Michael type addition, thus making covalent adducts with cy-
stein residues of the proteins. However, 2 and 3 showed both
low resistance index and high selectivity index, which make
them interesting as chemotherapeutic lead structures againstchloroquine resistant P. falciparum. Future improvements in
antimalarial chemotherapy based on sesquiterpene lactones could
originate from medicinal chemistry studies aiming at synthesis of
analogs with increased selectivity and lowered resistance index,
and further understanding of drug-delivery mechanisms, including
parasite transporter-based strategies (Biagini et al., 2005), opens
new horizons for targeting the increased mortality due to
drug-resistant malaria.
4. Experimental
4.1. General
Optical rotations were recorded using a Perkin–Elmer 241
polarimeter. NMR spectra of isolated compounds were recorded
at 25 C using a Bruker Avance 600 MHz equipped with a 5 mm
1H{13C} probe or a Bruker Avance 400 MHz spectrometer equipped
with a 5 mm 13C{1H} probe (1H resonance frequency 600.13 and
400.13 MHz, respectively). Spectra were calibrated using TMS as
internal standard. High-resolution mass determinations were car-
ried out using a Micromass LCT mass spectrometer equipped with
an electro-spray ion source operated in positive-ion mode. The
spectra were calibrated relative to Leu-Enkephalin (556.2771 g/
mol) added as an internal standard. Preparative-scale separations
were performed using an Agilent 1100 LC system (two preparative
pumps, an autosampler, a sample collector, and a multiple-wave-
length UV detector; controlled with ChemStation rev. B.01.01 soft-
ware; HPLC system I), a HPLC system consisting of a Waters 590
pump, a Rheodyne 7125 injector, and a Lambda-Max Model 481
LC UV detector (HPLC system II) or a Shimadzu HPLC system
(SCL-10A system controller, SIL-10AD autoinjector, LC-10AT pump,
CTO-10AC column oven, FRC-10A fraction collector, and SPD-M10A
PDA detector; controlled with Shimadzu Class-VP ver. 6.10 soft-
ware; HPLC system III). HPLC–PDA–MS–SPE–NMR experiments
were performed as described in details previously (Sprogøe et al.,
2008).
4.2. Plant material
Aerial parts of D. angulifolius (DC.) H. Rob. & B. Kahn [syn. V.
angulifolia DC.] (Asteraceae) were collected at an altitude of
665 m in the Botanical Garden of University of KwaZulu-Natal,
Pietermaritzburg, on January 5th 2006. The identity of the plant
was conﬁrmed by Professor T.J. Edwards and a voucher specimen
(Accession Number: Chukwujekwu #1 NU) has been deposited
in the Herbarium at the University of KwaZulu-Natal,
Pietermaritzburg.
Table 1
1H and 13C NMR spectroscopic data of 1 and 2.
Vernangulide A (1) Vernangulide B (2)
pos. dCa dH, (J in Hz)a,b HMBCc dCa dH, (J in Hz)a,b HMBCc
1 135.5 5.74 (ddd, J1,2A = 8.2, J1,2B = 8.2, J1,9B = 1.0) 9, 14 142.4 5.66 (dd, J1,2B = 17.8, J1,2A = 11.1) 10, 14
2 25.4 A: 1.92 (br, s) 114.7 A: 5.03 (dd, J2A,1 = 11.1, J2A,2B = 1.0) 1, 10
B: 2.70 (br, s) B: 5.00 (dd, J2B,1 = 17.8, J2B,2A = 1.0) 10
3 24.9 A: 2.78 (ddd, J3A,3B = 12.5, J3A,2A = 3.5, J3A,2B = 3.5) 1, 2, 4, 5, 15 140.4 A: 6.56 (s) 4, 5, 15
B: 2.30 (dddd, J3B,3A = 12.5, J3B,2A = 12.5, J3B,2B = 4.7, J3B,5 = 1.0) 1, 2, 4, 5, 15 B: 6.62 (s)
4 142.3 145.2
5 148.5 6.54 (dd, J5,6 = 10.4, J5,3B = 1.0) 3, 7, 15 46.7 3.36 (d, J5,6 = 12.3) 4, 6, 10
6 76.5 5.38 (dd, J6,5 = 10.4, J6,7 = 1.8) 4, 5, 7, 8, 11, 12 77.8 4.91 (dd, J6,5 = 12.3, J6,7 = 11.3)
7 49.6 3.43 (dddd, J7,8 = 9.8, J7,6 = 1.8, J7,13A = 1.8, J7,13B = 1.8) 5, 8, 9, 11, 12, 13 52.1 3.21, (dddd, J7,6 = 11.3, J7,8 = 11.0, J7,13A = 3.0, J7,13B = 3.0)
8 70.7 5.26 (ddd, J8,9B = 12.0, J8,7 = 9.8, J8,9A = 4.0) 6, 16 70.3 5.44 (ddd, J8,7 = 11.0, J8,9ax = 10.7, J8,9 eq = 4.3)
9 42.5 A: 2.51 (ddd, J9A,9B = 12.0, J9A,8 = 12.0, J9A,1 = 1.0) 1, 7, 8, 10, 14 40.5 ax: 1.86 (dd, J9ax,9 eq = 13.4, J9ax,8 = 10.7)
B: 2.81 (dd, J9B,9A = 12.0, J9B,8 = 4.0) 1, 7, 8, 10, 14 eq: 2.44 (dd, J9 eq,9ax = 13.4, J9 eq,8 = 4.3) 5, 7, 8
10 131.8 45.5
11 135.3 138.0
12 169.3 168.4
13 127.9 A: 6.25 (dd, J13A,7 = 1.8, J13A,13B = 1.8) 7, 8, 11, 12 120.2 A: 6.01 (d, J13A,7 = 3.0)
B: 5.87 (dd, J13B,7 = 1.8, J13B,13A = 1.8) 7, 8, 11, 12 B: 5.64 (d, J13B,7 = 3.0) 7
14 62.6 4.86 (2H, AB spin system) 66.3 A: 4.05 (d, J14a,14b = 11.8) 5, 9, 20
B: 4.28 (d, J14b,14a = 11.8) 1, 9, 20
15 195.0 9.52 (s) 195.3 9.60 (s) 4, 5
16 165.5 166.0
17 141.9 141.7
18 61.1 4.26 (2H, AB spin system) 16, 17, 19, 8 61.4 4.33 (2H, AB spin system) 17, 19
19 124.6 A: 5.94 (d, J19A,19B = 1.8) 16, 18 125.4 A: 5.97 (d, J19A,19B = 1.7) 18
B: 6.24 (d, J19B,19A = 1.8) 16, 18 B: 6.26 (d, J19B,19A = 1.7) 16, 18
20 170.9 171.2
21 20.8 2.09 (3H, s) 14, 20 21.1 2.09 (3H, s) 20
a 1H (600 MHz) and 13C (100 MHz) NMR spectral data measured in acetone-d6, d values relative to internal TMS.
b Multiplicity of signals is given in parentheses: s, singlet; d, doublet; br, broad; coupling constants (apparent splittings) are reported as numerical values in Hz.
c Signal correlating with 1H resonance, optimized for nJC,H = 7.7 Hz.
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Aerial parts (395 g) were successively extracted with dichloro-
methane/methanol 1:1 (2  2 l) and methanol (2  2 l) overnight
at room temperature. The combined extracts were concentrated
in vacuo, and freeze dried to give 67 g of raw extract. The extract
was defatted by redissolving in 1 l of methanol–water (9:1) and
extracting with petroleums ether (20  0.5 l, b.p. 80–100 C),
which yielded 56 g of defatted extract. Leaves (350 g) were sonica-
tion for 1 h with 1 l acetone and then left for extraction overnight.
Extraction was subsequently repeated three times with 0.5 l ace-
tone, and the combined extracts were evaporated under reduced
pressure at 30 C to give 19 g of extract.
4.4. HPLC–PDA–MS–SPE–NMR analysis
Separation of defatted extract was performed at 40 C on a
150  4.6 mm i.d. Phenomenex C18(2) Luna column (3 lm, 100 Å)
with a ﬂow rate of 0.8 ml/min using amixture of water–acetonitrileTable 2
Antiplasmodial and cytotoxic activity of 1-4 against P. falciparum D10 and W2 strains and
Compounds IC50 (lM)
D10 (n = 2)a W2 (n = 2)
1 1.90 ± 0.10 3.24 ± 0.27
2 1.55 ± 0.02 2.10 ± 0.17
3 3.82 ± 0.08 4.94 ± 0.18
4 1.75 ± 0.35 2.69 ± 0.26
Chloroquine 0.04 ± 0.004 0.16 ± 0.055
Emetine
a n = number of replicates.
b Resistance index = IC50 W2/IC50 D10.
c Selectivity index = IC50 CHO/IC50 D10.95:5 + 0.1% formic acid (eluent A) and acetonitrile–water
95:5 + 0.1% formic acid (eluent B). Five repeated separations (30 ll
injection volume, 100 mg/ml, gradient proﬁle: 0 min, 18% B;
13 min, 18% B; 28 min, 32% B; 43 min 32% B; 53 min, 100% B;
60 min, 100% B; 62 min, 18% B; 72 min 18% B)were performed using
UV threshold-based trapping (220 and 254 nm) of analytes on GP
phase SPE cartridges (general-purpose poly(divinylbenzene)-based
resin from Spark Holland, 10  2 mm i.d.; water post-column
dilution, 2 ml/min).
4.5. Preparative-scale isolation
Initial separation of defatted extract was performed with HPLC
system I on a 250  21.2 mm i.d Phenomenex C18(2) Luna column
(5 lm, 100 Å) with a ﬂow rate of 20 ml/min. Mixtures of water–
acetonitrile 95:5 + 0.1% TFA (eluent A) and acetonitrile–water
95:5 + 0.1% TFA (eluent B) were used for separation of 3.1 g
(900 ll pr. injection, 250 mg/ml solution) using the following gra-
dient proﬁle: 0 min, 25% B; 5 min, 25% B; 20 min, 32% B; 33 min,Chinese hamster ovarian cell line.
Resistance indexb Selectivity indexc
CHO (n = 3)
3.52 ± 1.63 1.7 1.9
8.28 ± 0.39 1.4 5.3
26.38 ± 1.85 1.3 6.9
4.47 ± 0.64 1.5 2.6
0.09 ± 0.04
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B. Manual collection based on absorption levels at 220 and 254 nm
afforded seven fractions (A–G) and 1H NMR spectra of the fractions
showed that only fraction A (34 mg) and fraction C (112 mg) con-
tained sesquiterpene lactones. HPLC system II and the above-men-
tioned HPLC column were used to rechromatograph fraction A and
C. Thus, isocratic elution of fraction A (water–acetonitrile–formic
acid 80:20:0.1) yielded 3.2 mg of (3) whereas isocratic elution of
fraction C (water–acetonitrile–formic acid 65:35:0.1) yielded frac-
tions C1–C5. Fraction C4 (2 mg, norartocarpetin and luteolin, 2:1
mixture) was not further puriﬁed, but fraction C2 (13 mg) and C5
(52 mg) were rechromatographed on HPLC system III using the
same HPLC column and eluents as for the HPLC–PDA–MS–SPE–
NMR analysis. Isocratic separation of 7.7 mg of fraction C2
(water–acetonitrile–formic acid 82:18:0.1) yielded 2.7 mg of 2:1
mixture of 6 and 7, whereas isocratic separation of 13.6 mg of frac-
tion C5 (water–acetonitrile–formic acid 80:20:0.1) yielded 1.3 mg
of 4 and 3.0 mg of 5.
4.6. Bioassay-guided isolation
Column chromatography (Merck 9385, 200 g, 2.5  73 cm) of
the acetone extract, using hexane–acetone step gradients (10:0,
9:1, 4:1, 7:3, 3:2, 1:1, 2:3, 3:7, 1:4, and 0:10; 0.5 l each), yielded
355 fractions which were pooled into 16 fractions based on simi-
larity of TLC proﬁles using UV light at 254 and 365 nm for visual-
ization. All fractions were assessed for antiplasmodial activity
against chloroquine sensitive D10 P. falciparum strain at concentra-
tions of 5, 2.5, and 1.25 lg/ml. Fractions 11 (1.197 g) and 12 (5.6 g)
eluted with hexane–acetone (7:3 and 3:2, respectively), were
found to be the most active. Repeated puriﬁcation of the two frac-
tions by column chromatography (Merck 9385, 120 g,
2.5  73 cm), using hexane–EtOAc step gradients (same as above),
produced 200 and 230 fractions, respectively. Fractions were again
pooled based on similar TLC proﬁles to give 17 (Fr11S1–Fr11S17)
and 15 (Fr12S1–Fr12S15) subfractions, respectively, which were
subjected to antiplasmodial bioassay. A ﬁnal puriﬁcation of con-
stituents from the active fractions were performed by preparative
TLC using a hexane–EtOAc (3:1) solvent system, and this yielded
14.5 mg of 1, 1 mg of 2, 13 mg of 3, and 59 mg of a mixture of 4
and 5.
4.7. Antiplasmodial assay
Continuous in vitro cultures of asexual erythrocyte stages of
chloroquine sensitive D10 strain and chloroquine resistant W2
strain of P. falciparum were maintained using a modiﬁed method
of Trager and Jensen (1976), and quantitative assessment of anti-
plasmodial activity in vitro was determined via the parasite lactate
dehydrogenase assay (Makler et al., 1993) as described in details
elsewhere (Clarkson et al., 2003; Pillay et al., 2007).
4.8. Cytotoxicity assay
Quantitative assessment of cytotoxicity was assessed with an
in vitro assay (Mosmann, 1983; Rubinstein et al., 1990) using the
Chinese Hamster Ovarian cell line as described previously (Clarkson
et al., 2003; Pillay et al., 2007).
4.9. Compound 1
Vernangulide A [(6S,7R,8S)-14-acetoxy-8-[2-hydroxymethylacrylat]-
15-helianga-1(10),4,11(13)-trien-15-al-6,12-olid] (1): ½a20D = 9.2
(c 0.68, CHCl3); 1H and 13C NMR data see Table 1; HREIMS m/z
427.1369 [M+Na]+ (calc. for [C21H24O8Na]+, 427.1363).4.10. Compound 2
Vernangulide B [(5R,6R,7R,8S,10S)-14-acetoxy-8-[2-hydroxymeth-
ylacrylat]-elema-1,3,11(13)-trien-15-al-6,12-olid] (2): ½a20D = +26.3
(c 17, CHCl3), 1H NMR and 13C NMR data see Table 1; HREIMS m/
z 427.1442 [M+Na]+ (calc. for [C21H24O8Na]+, 427.1363).Acknowledgement
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